Provexis Share Discussion Threads

[librag] 19/9/2017 16:00

It's good to learn. Try it.

[lafin] 19/9/2017 15:52

Of course I won't understand a word of it so I won't bother reading it.

[lafin] 19/9/2017 15:47

New book by Asim Duttaroy called "Nutraceuticals and Human blood platelet function: Application in Cardiovascular Health ".

Says on his website It will be published by Wiley, UK, in July, 2017.

[librag] 19/9/2017 15:40

Your quote is apt ... look in the mirror, a shortened version is better.
"You can't see that you cannot think".

If you don't understand the nuances of our IP, perhaps it might be better if you posted less and read more.

[lafin] 19/9/2017 14:44

You can't see that you cannot think outside of your medical training.

[lafin] 18/9/2017 23:01

He won't like that!
Thanks BB.
I was attempting(and failing) to make it look scientific which was a bit ridiculous as I am not a scientist.

[bareknee] 18/9/2017 21:58

Lafin

Re "There is no terminology for people who may be at risk of future ailments .."

Actually, there is, and you've already stated it, it's called "at risk" , which basically means some people are, from a statistical point of view, significantly more likely to suffer serious medical problems than other people of their age / background etc.

Plainly, when it comes to CVD, taking a Fruitflow pill isn't their only option, they could, for example :-

Quit Smoking and / or
Exercise More and / or
Drink Less and / or
Eat a healthy Mediterranean diet

But most won't, and, if people like Graham, who understand the risks of the above, continue to be lethargic porkies who want a quick fix, then the trick, from a business perspective, is to sell them the quick fix and take their money. The fact that it'll probably do them some good is an added bonus

BB

[lafin] 18/9/2017 17:21

That was a guess.

[lafin] 18/9/2017 17:15

There is no terminology for people who may be at risk of future ailments so they have to use medical terminology.

[lafin] 18/9/2017 17:07

You are nit picking just so you can type something.

[lafin] 18/9/2017 14:39

Why would you want a silly discussion like that on a share board about a product which is intended to be a dietary supplement?

It is NOT intended for ILL people.

It's for people who do not want to become ill.

[librag] 18/9/2017 13:20

From 2008.
hxxps://www.researchgate.net/publication/23567799_The_Effects_of_Natural_Antioxidants_from_Tomato_Extract_in_Treated_but_Uncontrolled_Hypertensive_Patients

Just tomato extract (equivalent to 4 medium size tomatoes), not FF. Works though, so we're back to diet vs supplements ... discuss.

[librag] 18/9/2017 12:45

Good news, FF reduces blood pressure in pre-hypertensive subjects. Not the same as saying it will work with truly hypertensive patients but it's a good start. Be nice to know by how much.
ACEIs are big business.

[lafin] 18/9/2017 12:17

Some Blood pressure research found by gixer



Abstract

In order to investigate whether the angiotensin converting enzyme-inhibitory tomato extract Fruitflow® would lower blood pressure after consumption, we conducted a randomised, double-blinded, placebo-controlled human intervention study, involving 12 pre-hypertensive people in a crossover design. Consuming a single dose of 150 mg Fruitflow® resulted in a significant reduction in 24-hour average blood pressure as well as average wake-period and sleep-period SBP, compared to placebo. Other parameters related to blood pressure, such as 24-hour average mean arterial pressure, pulse pressure, heart rate, central aortic systolic pressure and radial augmentation index were also reduced. In addition, the platelet aggregation response to ADP, measured 24 hours after consuming Fruitflow®, fell significantly compared to baseline, and compared to placebo. This pilot study clearly shows the beneficial effects of Fruitflow® on two important cardiovascular risk factors, high blood pressure and platelet hyperactivity.

[lafin] 14/9/2017 13:25

AND
"The company and its commercial partner DSM saw an encouraging increase in brand awareness and customer interest in Fruitflow in recent months.

The total projected annual sales value of the prospective sales pipeline for Fruitflow now stands at a new all-time high level."

This will be since March.

[lafin] 13/9/2017 10:59

Oh for goodness sake.
Read Senor Sensible's post above.He is trying to help you I think.
His post makes sense.

[wheelds] 10/9/2017 02:46

Revenue of GBP227,618 this time and if more then doubles again then we will have revenue of over £500,000 next year and hopefully the admin, selling, and distribution costs will be a lot less.
And of course we will also benefit once By-Health, in partnership with DSM and Provexis launches the new Fruitflow healthy heart products to the estimated 300 million Chinese potential customers.

Report states New product development and launches? And Revenue more then doubled.!
Well, Fruitflow plus Omega 3 is the only new product I know of so it sounds like new products are ready to be launched.IMHO
However, more than doubling revenues sounds good, and if this increase in revenue continues and if the high administrative, selling and distribution costs due to new product development and launches is now under control, next results should shine. IMHO
Report:-
"The company, focused on the development of its Fruitflow food supplement, reported a pretax loss of GBP425,531 for the year ended in March, narrowed slightly from a loss of GBP452,711 the prior year, on revenue of GBP227,618, more than doubled from from GBP91,649."

"The rise in revenue was partly offset by more administrative, selling and distribution costs, as Provexis invested in new product development and launches."
Sounds like new products ready to be launched and the costly development costs etc has been covered as the above pretax loss highlights.IMHO
So, all looking good as long as the costly development of the new products gets launched this year in China and around the world.IMHO

[senor_sensible] 07/9/2017 09:13

lol, AIM is a market providing seed money to small companies with the hope it will bear fruit in the future. Most pricing on AIM is speculative. if you want companies with massive turnover there are other markets such as FTSE350 to look for.

PXS has been ramped, pumped and dumped in the past, which has helped finance the development of the product which is now bringing in revenue, albeit less than 1Mil last year, but the key is the revenue growth. if that continues to the point where this is self funding which could be in the next year then dilution ends. Any further revenue growth or moving into new markets, etc will underpin good shareprice rises. IMO buying in at this price is fairly de-risked but be prepared to hold and ride out any pump and dump related dips. If looking to turn a fast profit you need to be one step ahead.

[senor_sensible] 07/9/2017 07:47

Hopefully the headline will get attention

Provexis sales surge by 148%

[senor_sensible] 06/9/2017 10:39

Are we due some results to be announced soon???

[wheelds] 02/9/2017 20:57

Report all about the growing economic benefits of nutritional foods and mentions Fruitflow AND By-Health as one of China's Largest health products manufacturers who as we all know is now in collaboration with us and DSM to produce Fruitflow products in China for its 230 million and growing suffering from heart health problems:-

"Economic Impact of the Strategic Research Programme 2011-2016.
A report to the Scottish Government August 2017.
BiGGAR Economics,
BiGGAR Economics Pentlands Science Park Bush Loan, Penicuik Midlothian, Scotland EH260PZ+44 (0)131 514 0850 [e-mail] economics"

12.1 Functional Foods:-
"Fruitflow. In 2016, Provexis concluded a collaboration agreement with By-Health, one of China’s largest health products manufacturers. The agreement aims to target the creation of new products for the estimated 230 million people in China with cardiovascular problems."
"Fruitflow could therefore generate significant benefits. Although it is not possible to quantify the economic contribution of Fruitflow, it nevertheless provides an example of successful functional food product development and commercialisation founded from SRP funded research."